Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

15 Jul 2011 07:00

RNS Number : 4487K
Alumasc Group PLC
15 July 2011
 



 

For release 7am, 15 July 2011

 

THE ALUMASC GROUP PLC - TRADING UPDATE

 

The Alumasc Group plc (ALU:L), the premium building and engineering products company, is providing a trading update relating to the year ended 30 June 2011.

 

Group revenues are expected to be in line with previous expectations. However, margins in the Building Products division for the fourth quarter were significantly lower than expected as a result of rising input costs that could not be recovered fully from customers, against a background of continued weakness in the UK construction market. In particular, the group's Construction Products business experienced a 20% increase in steel costs towards the end of the financial year, with profitability further diluted by an increase in the proportion of lower margin export sales. Consequently, underlying group profit for the full year is expected to be ahead of last year, but below previous management expectations.

 

Net cash flow performance to the year end continued to be robust and remained ahead of expectations.

 

Alumasc Precision recovered strongly during the year, benefiting from international demand for aluminium components used mainly in off-highway diesel engines, and particularly those used in mining and construction vehicles being sold into emerging economies. In view of the strong resurgence at Alumasc Precision over the last eighteen months and the encouraging future prospects for this business, the impairment charge booked in 2009 is to be reversed. This will give a one-off, non-cash gain of £1.2 million in the financial year just ended. As a consequence, the group's statutory profit before tax is expected to exceed underlying profit, and be well ahead of the prior year statutory result.

 

This impairment charge reversal will increase the book value of plant and equipment and therefore give rise to a higher depreciation charge of £0.3 million per annum in the 2011/12 financial year and beyond.

 

There is early evidence that a greater number of large buildings are now beginning to be funded, which could benefit Levolux, in particular, in the group's 2012/13 financial year. This is broadly consistent with external construction industry forecasts as to the expected timing of a return to growth. In the meantime, export sales strategies are beginning to add incrementally to Alumasc's revenues, and there are numerous initiatives across the group to mitigate the impact of the specific current weakness in the UK commercial new build sector, diversify routes to market and introduce new and innovative products.

 

Alumasc Precision continues to grow, although it is anticipated that growth will be at a more sustainable rate whilst the business prepares for the next phase of the project won last October to supply components for larger engine transmission systems, expected to start late in 2012.

 

In view of the continued strong group order book at Alumasc Precision, and the factors outlined above, the Board expects Alumasc to continue to make steady progress in 2011/12.

 

The Board will review the group dividend ahead of the announcement of its full year results in September in the light of current trading and future prospects at that time.

 

The results for the year ended 30 June 2011 will be announced on Tuesday, 6th September 2011. A presentation to analysts will be made at 9.30am on that day, at the offices of Peel Hunt, 111 Old Broad Street, London EC2N 1PH.

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield or James Irvine-Fortescue Tel: 0207 367 8861

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFADAISLIL
Date   Source Headline
13th May 20217:00 amRNSTrading Update
13th Apr 20212:13 pmRNSDirector/PDMR Shareholding
9th Apr 20213:16 pmRNSDirector/PDMR Shareholding
19th Feb 20211:30 pmRNSDirector/PDMR Shareholding
5th Feb 202112:20 pmRNSDirector/PDMR Shareholding
4th Feb 20217:01 amRNSAppointment of Group Finance Director
4th Feb 20217:00 amRNSInterim results
19th Jan 20219:05 amRNSSecond Price Monitoring Extn
19th Jan 20219:00 amRNSPrice Monitoring Extension
19th Jan 20217:00 amRNSTrading Statement
18th Nov 20203:20 pmRNSDirectorate Change
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20203:30 pmRNSResult of AGM
22nd Oct 20207:00 amRNSAGM Trading Update
15th Oct 20201:01 pmRNSDirector/PDMR Shareholding
21st Sep 20201:30 pmRNSNotice of AGM
8th Sep 20207:00 amRNSFull Year Results
19th Aug 202011:49 amRNSNotice of Results
7th Aug 20202:30 pmRNSDirector/PDMR Shareholding
3rd Aug 202011:32 amRNSHolding(s) in Company
29th Jul 202011:52 amRNSDirector/PDMR Shareholding
27th Jul 20202:51 pmRNSDirector/PDMR Shareholding
27th Jul 202012:13 pmRNSDirector/PDMR Shareholding
27th Jul 20208:51 amRNSDirector/PDMR Shareholding
27th Jul 20208:51 amRNSDirector/PDMR Shareholding
23rd Jul 20207:00 amRNSTrading Statement
9th Jun 20201:30 pmRNSHolding(s) in Company
19th May 20207:00 amRNSContract wins
11th May 20202:30 pmRNSDirector/PDMR Shareholding
29th Apr 20202:14 pmRNSHolding(s) in Company
27th Apr 20207:00 amRNSCOVID-19 Further Update
23rd Apr 202011:48 amRNSResults of General Meeting
16th Apr 20203:27 pmRNSDirector/PDMR Shareholding
7th Apr 20202:31 pmRNSDirector/PDMR Shareholding
1st Apr 20203:48 pmRNSCOVID-19 Update
31st Mar 202011:00 amRNSNotice of GM
27th Mar 20207:00 amRNSCOVID-19 Update
20th Mar 20202:39 pmRNSDirector/PDMR Shareholding
19th Mar 20203:00 pmRNSDirector/PDMR Shareholding
12th Mar 20202:30 pmRNSHolding(s) in Company
2nd Mar 202010:24 amRNSHolding(s) in Company
26th Feb 202012:38 pmRNSHolding(s) in Company
4th Feb 20207:00 amRNSInterim Results
8th Jan 202011:20 amRNSNotice of Results
1st Nov 20192:26 pmRNSHolding(s) in Company
1st Nov 20192:22 pmRNSHolding(s) in Company
24th Oct 20193:30 pmRNSResult of AGM
24th Oct 20197:00 amRNSAGM Statement
17th Oct 201910:30 amRNSDirector/PDMR Shareholding
2nd Oct 20193:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.